Claudin-low breast cancer (CLBC) is a poor prognosis disease biologically characterized by stemness and mesenchymal features. These tumors disproportionately affect younger patients and women with African ancestry, causing significant morbidity and mortality, and no effective targeted therapy exists at present. CLBC is thought to originate from mammary stem cells, but little is known on how or why these tumors Further, they suggest that targeting PI3Kγ may prove beneficial for the treatment of claudin-low breast cancer subtype.
Introduction
Gene expression profiling has been used to subclassify human breast cancer into at least six molecular subtypes, including Basal-like, Claudin-low, HER2-enriched, Luminal A, Luminal B and Normal-like. Claudin-low breast cancer (CLBC) shares features with mammary stem cells and CLBC cells have undergone epithelial-to-mesenchymal transition (EMT) (1, 2) . It is widely believed that cancer stem-like cells play a key role in tumor recurrence and metastasis. Also, accumulating evidence suggest that EMT promotes dissemination, and may itself promote "stemness" (3) (4) (5) .
Notch signaling controls mammary stem cell self-renewal and differentiation, and may regulate EMT in breast cancer cells (6) (7) (8) (9) . Indeed, dysregulated Notch activation has been implicated in breast cancer, especially in subtypes showing features of mammary stem cells and EMT (10) . As a result, Notch has emerged as a potential drug target for poor prognosis breast cancer. However, the role of Notch in different subtypes is not clear, nor is the specific Notch receptor(s), ligand(s), and the modulator(s) involved. 5 compared to other subtypes. In contrast, expression of MFNG was significantly higher in CLBC. In this study, we performed loss-of-function analysis for Mfng in CLBC cell lines as well as mouse models to determine roles for Mfng in CLBC. We also identified a critical downstream effector of Mfng-modulated Notch signaling in this context.
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Materials and Methods

Cells
MDA-MB231 was obtained from ATCC. Mouse cell line C0321 was established and maintained as previously described (13) . Cells were resuscitated from early passage liquid nitrogen stocks and cultured less than 3 months before reinitiating cultures. Cells were tested negative for mycoplasma contamination.
Cell proliferation, migration, and tumorsphere assays, drug treatment, and xenograft experiment Cell proliferation was assessed using CellTiter96 AQueous One Solution kit (Promega). Collective cell migration was measured in a wound-healing assay.
Tumorespheres were cultured as previously described (13) , and quantified using a cytometer (Celigo). For drug treatment, cells were incubated with AS-605240 (Selleck, S1410) at a final concentration of 10 μM. Xenografts were performed by injecting a total of 1 x 10 6 cells mixed with Matrigel (BD Bioscience) into the mammary fat pad in 4-week-old ICR/SCID mice (Taconic). 
Western blot analysis and flow cytometry
Histology, immunohistochemistry and X-Gal staining
Formalin-fixed paraffin-embedded tissues were processed for histological and immunohistochemical analysis by standard procedures (see supplementary methods for primary antibodies used for IHC). Representative images were acquired with a Nikon Eclipse 80i microscope. X-Gal staining in the mammary gland was performed as previously described (12) .
Microarray gene expression analysis in xenografts
Total RNA was extracted from xenografts using RNeasy Mini Kit (Qiagen), and processed using the Ambion WT Expression Kit 
Gene expression analysis of human data set
Human breast cancer gene expression data set GSE18229 was downloaded from GEO (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18229). Expressions of MFNG, NOTCH4 and PIK3CG and clinical information of patient samples were extracted by an in-house Java parser. Averaged values were used if more than one probe was mapped to same genes. All plots and analyses were performed using R (http://www.r-project.org). p value was calculated by comparing expression means across all subtypes.
CHIP, luciferase reporter assays
ChIP assay was performed using EZ-ChIP kit (Millipore). Briefly, MDA-MB231 cells were treated with 1% formaldehyde, neutralized, and resuspended in SDS lysis buffer for chromatin fragmentation with sonication (ultrasonic processor GE130). 
shRNA, quantitative RT-PCR
The MFNG-shRNA construct targeting 5′-GTGCTGGCTTCTGCATCAATCGCAAACTG-3′ sequences of MFNG gene was purchased from Origene. MDA-MB231 and C0321 cells were transfected with the shRNA or scrambled control plasmid using FuGENE 6 Transfection Reagent (Promega).
Stable cell lines expressing shRNA were generated by selection with Puromycin. For quantitative RT-PCR, total RNA was extracted using RNeasy Mini kit and reverse transcribed using iScript cDNA synthesis kit (Bio-rad). PCR was performed using QuantiTect SYBR Green PCR Kit (Qiagen) and quantitated with BioRad CFX96 qPCR System (see supplementary methods for primer sequences).
Statistics
Unpaired two-tailed t-tests were performed for two group comparisons, and p value of 0.05 or less was considered statistically significant. 
Accession codes
The microarray data have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession number GSE62481.
Results
Modulation of Notch activation by Mfng in CLBC cell lines and in the mouse mammary gland
In a survey for Notch pathway gene expression in a human breast cancer data set, GSE18229 (1), we found that MFNG expression is significantly higher in CLBC as ;MMTV-Cre mice also showed elevated Mfng expression (12) . Moreover, using SAM analysis on 385 mouse mammary tumor samples from 27 models, Mfng and Notch4 are found to be expressed at significantly higher levels in claudin-low subtype tumors than in tumors from all other subtypes (14) . Thus, Mfng is up-regulated in CLBC in both humans and mice.
To determine the function of Mfng in CLBC, we performed MFNG-knockdown in MDA-MB231, a human breast cancer cell line with a claudin-low gene expression signature (1, 2) . To this end, we selected a polyclonal cell population transfected with a MFNG shRNA expression vector. This population showed a 40% decrease in MFNG mRNA expression as well as a decrease in Notch1 and Notch4 protein accumulation as compared to control cells ( Fig. 1C and D) . Importantly, the size of Notch1 and Notch4 (Fig. 1C) . We also knocked down Mfng in a murine Claudin-low cell line, C0321 (13) . In this case, shRNAexpressing cells showed a 60% reduction in Mfng mRNA and decreased N4-ICD accumulation, but increased level of N1-ICD (Fig. 1C and D) . shMfng C0321 cells showed decreased mRNA levels of Hes1 and Hes5, but increased Hey1 expression (Fig.   1C ).
We next examined Mfng expression in the mouse mammary gland using a Mfng 
Knockdown of Mfng had no effect on the growth of MDA-MB231 or C0321 cells cultured on plastic (Supplementary Fig. 2 ), however, it dramatically decreased tumorsphere-forming capacity of both lines (Fig. 2A) (Fig. 2C) . Mfng-knockdown cells showed a lower migration rate in the "wound healing" assay (Fig. 2D) . ;MMTVcre model. The Claudin-low subtype, which often displays spindloid histology (12), was not found (Fig. 3B) . Unlike basal-like and claudin-low tumors, the adenosquamous carcinoma showed nuclear staining of ERα and PR in some cells (Fig. 3C ).
Adenosquamous carcinoma was never found in more than 50 tumors collected from ;MMTV-cre mice express more Notch4 and less Notch1 (12, 13) . Consistent with a subtype shift away from claudin-low, we observed a decrease in Notch4 and increase in Notch1 protein accumulation in Mfng-knockdown C0321 cells (Fig. 1D ). Table 1, and Supplementary Fig. 3 ). Encoding the γ catalytic subunit of phosphatidylinositol-4,5-bisphosphate 3-kinase, PIK3CG has recently been shown to promote breast cancer growth and metastasis (17, 18) . We verified that knockdown of Mfng caused a dramatic decrease in Pik3cg level, as well as reduced Akt phosphorylation in CLBC cells (Fig.   4A ). Since knockdown of Mfng decreased Notch1 and Notch4 activation in MDA-MB231, we tested whether Mfng controls Pik3cg expression through Notch1 or Notch4.
Pik3cg is a direct target of Mfng-enhanced Notch signaling in CLBC
Indeed, overexpression of N1-ICD and/or N4-ICD resulted in increased Pik3cg protein level in MDA-MB231 cells (Fig. 4B) . The PIK3CG gene promoter harbors multiple consensus Rbpjκ-binding sites, including two in a region less than 1 Kb upstream of the start codon. To test for Rbpjκ-binding to these sequences, we performed chromatin immunoprecipitation (ChIP). Sequences surrounding both sites were amplified from the Rbpjκ-chromatin complex. Luciferase reporter assay using constructs from the PIK3CG promoter, including one or both Rbpjκ-binding sites revealed that both sites are required for the Notch-ICD dependent transcriptional activation (Fig. 4B) . Thus, Pik3cg is a direct target of Rbpjκ-dependent Notch signaling in CLBC cells. Moreover, PIK3CG expression positively correlates with MFNG expression in human breast tumors (p-value < 2.2e-16, Fig. 4C and Supplementary Table 2) . Also, PIK3CG, but not PIK3CA, is highly expressed in CLBC subtype (Fig. 4C, and data not shown) 
Next we tested for the importance of Pik3cg in CLBC cells using a selective PI3Kγ inhibitor, AS-605240. "Wound healing" assays showed that inhibition of PI3Kγ activity almost completely blocked the migration of C0321 cells, and significantly attenuated that of MDA-MB231 (Fig. 4D) . The same concentration of AS-605240 had no effect on growth of MDA-MB231, and did not impede C0321 proliferation until 2 days after treatment ( Supplementary Fig. 4 ), indicating that failed "wound healing" is not due to (Fig. 4D) . Indeed, treatment with AS-605240 resulted in a dramatically decreased capacity of tumorsphere formation in both cell lines (Fig. 4D) . Taken together, PI3Kγ activity is not only required for cell migration, but also contributes to maintenance of claudin-low cancer stem-like cells.
Discussion
Multiple Notch receptors are expressed in the developing mammary gland and in breast cancer, and individual Notch receptors may exert distinct roles in different mammary cell types. For instance, Notch4 has been shown to regulate self-renewal of stem or bipotential progenitor cells (8, 20) , whereas Notch3 is reported to function in luminal progenitor cells (8, 21) . In this study, we found that MFNG expression in breast cancer is highly correlated with expression of NOTCH4, but not with expression of other (Fig.1D) , suggesting that overall reduction in Notch signaling may lead to squamous differentiation of the mammary epithelium.
Interestingly, inactivating mutations in Notch pathway genes have been identified in squamous cell carcinoma of other tissues including head and neck, lung and bladder (23).
Pik3cg is aberrantly expressed in many invasive human breast tumors and its expression level correlates with metastatic potential of breast cancer cell lines (18 (17, 18) . Our results suggest that Pik3cg contributes to breast cancer aggressiveness not only by promoting cell migration, but also by maintaining cancer stemness.
In conclusion, this study revealed a novel oncogenic role for Mfng in CLBC. Our discovery of a specific role of Mfng-controlled Notch signaling in CLBC provides new insights into the regulation of cancer stem cells in specific breast cancer subtypes. 
